---
title: 'Senior Director / Director, Global Medical Affairs (Evidence Generation) at Scholar Rock'
canonical: 'https://feeny.ai/job/senior-director-director-global-medical-affairs-evidence-generation-scholar-vv3sy40yn3ky'
type: 'job'
last_seen: '2026-11-08'
---

# Senior Director / Director, Global Medical Affairs (Evidence Generation) at Scholar Rock

- **Company:** Scholar Rock
- **Location:** Cambridge, MA
- **Compensation:** $200k–$325k
- **Employment:** full-time
- **Work type:** hybrid
- **Posted:** 2026-11-02
- **Last confirmed live:** 2026-11-08
- **Apply:** https://jobs.lever.co/scholarrock/80550f89-961a-4d31-b627-c153f67d83aa

## Job description

Scholar Rock is delivering muscle-targeted breakthroughs to transform the treatment of spinal muscular atrophy (SMA) and other rare neuromuscular diseases where muscle atrophy remains a critical unmet need. As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the biopharmaceutical company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more about our neuromuscular franchise at ScholarRock.com and follow @ScholarRock on X and on LinkedIn.

Summary of Position:

Position Responsibilities

- Strategic Leadership: Lead the development and execution of global evidence generation strategies that support product value demonstration, reimbursement, market access, and lifecycle management.
- Study Design & Oversight: Direct the design, implementation, and operational oversight of medical affairs-led evidence generation initiatives, ensuring all protocols are executed in strict compliance with global regulatory, ethical, and corporate quality standards. Core modalities include:
- Prospective and retrospective observational studies
- Real-world evidence (RWE) studies and database analyses
- Patient-reported outcome (PRO) research
- Qualitative and quantitative primary research
- Phase IV studies and post-hoc analyses
- Cross-Functional Collaboration: Partner strategically with cross-functional teams to integrate evidence generation strategies into commercial evaluations and portfolio management decisions, successfully demonstrating product value to achieve global market access.
- External Stakeholder Engagement: Establish and maintain robust relationships with external experts, including key opinion leaders (KOLs), clinical researchers, and healthcare decision-makers, to accurately inform evidence needs and study designs.
- Scientific Dissemination: Partner with Medical Communications to develop publication and dissemination strategies that maximize the impact, scientific rigor, and visibility of evidence generation findings.
- Team Development: Support the development and training of global and regional Medical Affairs teams on evidence generation strategies, methodologies, and key study results.
- Project & Resource Management: Efficiently manage multiple evidence generation projects, key performance indicators (KPIs), and associated resources simultaneously, including budgets, CROs/vendors, and external collaborations.
- Culture Driver: Foster a culture of scientific rigor, innovation, compliance, collaboration, and patient focus across all evidence generation activities.

Candidate Requirements

- Education: MD, PhD, or PharmD or equivalent advanced degree in a relevant life sciences discipline.
- Experience & Track Record:
- Director level: Minimum 3–5 years of experience in Evidence Generation, Real-World Evidence, Outcomes Research, or related functions within the pharmaceutical, biotechnology, or life science industry.
- Senior Director level: Minimum 6–8+ years of experience in the tracking, design, and executive delivery of complex global evidence generation strategies within the biopharmaceutical industry.
- Documented track record of delivering measurable project results and cross-functional success.
- Core Competencies: Strong written and verbal communication skills, exceptional interpersonal capabilities, and proven experience managing external vendor relationships.
- Therapeutic Area: Prior experience in neuromuscular diseases and/or rare diseases is highly preferred but not required.
- Travel: Ability to travel domestically and internationally (~15%).

Scholar Rock is an Equal Opportunity Employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.

## About Scholar Rock

## Company Overview
- **One-liner**: Scholar Rock is a biopharmaceutical company discovering and developing selective therapies targeting growth factors for serious diseases with high unmet need.
- **Entity Type**: Public (NASDAQ: SRRK)
- **Headquarters**: Cambridge, Massachusetts, United States
- **Founded**: 2012
- **Founders**: Not publicly available

## Core Business
- **Primary industry**: Biotechnology / Biopharmaceuticals
- **Target customers**: Patients suffering from neuromuscular disorders, cancer, fibrotic diseases, and hematologic conditions; healthcare providers and payers
- **Mission**: “Turning scientific discoveries into a pipeline of investigational therapies aimed at diseases where growth factors play a central role.”

## Products & Services
- **Apitegromab (SRK-015)**: A selective anti‑latent myostatin antibody in Phase 3 for spinal muscular atrophy (SMA). BLA resubmission and U.S. launch anticipated in 2026.
- **SRK‑181**: A selective anti‑latent TGFβ1 antibody for locally advanced or metastatic solid tumors (immuno‑oncology).
- **SRK‑373**: A context‑dependent anti‑latent TGFβ1 antibody for multiple fibrotic indications.
- **SRK‑256**: A selective anti‑RGMc/HJV antibody for hematology indications.
- **Proprietary Platform**: Broad technology for generating monoclonal antibodies that selectively target latent forms of growth factors (TGFβ superfamily).

## Market Standing
- **Valuation/Market Cap**: $2.8 B (as of search date, 2026‑09‑06)
- **Key Metric**: Annual revenue $0 (pre‑commercial); IPO in 2018
- **Notable Investors/Partners**: Not publicly available
- **Growth Signals**: Headcount grew 27.4% YoY to 278 employees; workforce across 7 countries; 20,522 LinkedIn followers (+45.9% yearly); first company to show clinical proof‑of‑concept for a muscle‑targeted treatment in SMA.

## Competitive Advantages
- First‑in‑class platform for selectively targeting latent growth factors (TGFβ superfamily), enabling high specificity and reduced off‑target effects.
- Proven clinical proof‑of‑concept in SMA with apitegromab, a novel mechanism.
- Broad pipeline spanning neuromuscular, oncology, fibrosis, and hematology, with multiple programs in Phase 2/3.

## Strategic Focus
- Advance apitegromab toward regulatory submission and commercial launch in SMA.
- Expand pipeline into cardiometabolic disorders and other growth‑factor‑driven diseases.
- Leverage platform to address historically under‑addressed disease areas.

## Why Work Here
- **Culture**: “Passion for science” and “every voice counts” – a collaborative, trust‑based environment focused on changing patients’ lives.
- **Work Policy**: Hybrid (e.g., Senior Director, Business Analytics in Cambridge, MA) and on‑site roles available.
- **Benefits**: Competitive health/dental/vision plans, life/AD&D insurance, short‑ and long‑term disability, paid parental leave, 401(k) match, financial wellness program, professional development, free parking/transit pass, onsite fitness center, weekly community lunches, peer‑to‑peer recognition.
- **Engineering/Science Culture**: Emphasis on innovation, cross‑functional teamwork, and direct impact on serious diseases.

## Sources
1. [scholarrock.com – Company Overview](https://scholarrock.com/our-company/careers/)
2. [scholarrock.com – Investors & Media](https://scholarrock.com/investors-media/)
3. [scholarrock.com – Pipeline](https://scholarrock.com/our-pipeline/)
4. [jobs.lever.co/scholarrock – Open Positions](https://jobs.lever.co/scholarrock)
5. [linkedin.com/company/scholar-rock – Company Profile](https://linkedin.com/company/scholar-rock)

## Other roles at Scholar Rock

- [Director, Learning & Development, EMEA](https://feeny.ai/job/director-learning-development-emea-scholar-rock-zug-rhncqzbktf34) — Zug, Switzerland
- [Director/Senior Director Medical Affairs EMEA](https://feeny.ai/job/director-senior-director-medical-affairs-emea-scholar-rock-zug-p9bcxh80qehk) — Zug, Switzerland
- [Associate Director, Medical Communications, EMEA](https://feeny.ai/job/associate-director-medical-communications-emea-scholar-rock-zug-s0j9z07w5sxe) — Zug, Switzerland
- [Manager/Senior Manager, Medical Information, EMEA](https://feeny.ai/job/manager-senior-manager-medical-information-emea-scholar-rock-zug-5hynwej90da9) — Zug, Switzerland
- [Senior Director, Enterprise Data & Analytics](https://feeny.ai/job/senior-director-enterprise-data-analytics-scholar-rock-cambridge-fd3kyczx97bt) — Cambridge, MA
- [Associate Director, Medical Affairs Operations](https://feeny.ai/job/associate-director-medical-affairs-operations-scholar-rock-cambridge-r70b4ht53zrz) — Cambridge, MA
- [Senior Scientist II, Upstream Process Development and MSAT](https://feeny.ai/job/senior-scientist-ii-upstream-process-development-and-msat-scholar-rock-cambridge-95jr4cxt29by) — Cambridge, MA
- [Senior Director, Patient Advocacy & Communications Lead, EMEA](https://feeny.ai/job/senior-director-patient-advocacy-communications-lead-emea-scholar-rock-zug-e7wdbg9mhgqj) — Zug, Switzerland
- [Director, External & CMC Quality Assurance](https://feeny.ai/job/director-external-cmc-quality-assurance-scholar-rock-cambridge-t2bkz2tbxrw6) — Cambridge, MA
- [Director, International Indirect Tax](https://feeny.ai/job/director-international-indirect-tax-scholar-rock-dublin-yat476xmdnaz) — Dublin, Ireland